Hanem Mohamed Rabah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hanem Mohamed Rabah has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Sarah Ragab Abd El-Khalik
Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, Egypt
2 shared publications Alia Mahmoud
Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine Zagazig University Zagazig Egypt
1 shared publicationAlzahraa A. Allam
Department of Internal Medicine, Faculty of Medicine, Tanta University, Egypt
1 shared publicationAmal M. Abdelsattar
Anatomy Department, Faculty of Medicine, Tanta University, Tanta, Egypt
1 shared publication- Amina M. Salama
Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
1 shared publication - Amira Kamel Eltokhy
Medical Biochemistry Department Faculty of Medicine Tanta University Tanta Egypt tanta.edu.eg
1 shared publication
Latest Publications
- 25 February 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (3) , e70193
Protective Effects of Galangin Against Cyclophosphamide‐Induced Cardiotoxicity via Suppressing NF‐κB and Improving Mitochondrial Biogenesis
Cyclophosphamide (CYP) is an effective chemotherapeutic and immunosuppressive agent; however, its clinical application is limited by a variety of toxic side effects. Mitochondrial dysfunction has been associated with the pathogenesis of chemotherapy‐induced cardiotoxicity. This work aimed to evaluate the possible protective effect of galangin (Gal) on CYP‐induced cardiotoxicity, pointing to its ability to promote mitochondrial biogenesis. Thirty two male rats were allocated equally into four groups: control; Gal‐treated; CYP‐treated; and Gal + CYP‐treated groups. Markers of cardiac injury, oxidative/antioxidant status, inflammation, apoptosis, and mitochondrial function were assessed in addition to histopathological and electrocardiographic (ECG) evaluation. The current results revealed that Gal treatment significantly attenuated the cardiac injury and retrieved the alterations in cardiac histopathology and ECG changes. Also, it restored redox balance, as evidenced by the alleviation of malondialdehyde (MDA) levels and increased glutathione peroxidase (GPx) activity. Gal activated the sirtuin (SIRT) 1/nuclear factor erythroid 2‐related factor 2 (Nrf2)‐mediated signaling pathway, as indicated by upregulation of SIRT1, Nrf2, SIRT3, and mitochondrial transcription factor (TFAM), in addition to increased levels of superoxide dismutase 2 (SOD)2 and peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α), together with increased activity of citrate synthase (CS), pointing to improved mitochondrial function. It ameliorated the inflammation and apoptosis‐associated markers supported by biochemical and immunostaining data. Our study provided novel insights elucidating the mitigative potential of against CYP‐induced cardiac oxidative damage, inflammation, apoptosis, and mitochondrial dysfunction by upregulating the SIRT1/Nrf2/SIRT3/PGC‐1α/TFAM survival pathway.
- 25 February 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (3) , e70193
Protective Effects of Galangin Against Cyclophosphamide‐Induced Cardiotoxicity via Suppressing NF‐κB and Improving Mitochondrial Biogenesis
Cyclophosphamide (CYP) is an effective chemotherapeutic and immunosuppressive agent; however, its clinical application is limited by a variety of toxic side effects. Mitochondrial dysfunction has been associated with the pathogenesis of chemotherapy‐induced cardiotoxicity. This work aimed to evaluate the possible protective effect of galangin (Gal) on CYP‐induced cardiotoxicity, pointing to its ability to promote mitochondrial biogenesis. Thirty two male rats were allocated equally into four groups: control; Gal‐treated; CYP‐treated; and Gal + CYP‐treated groups. Markers of cardiac injury, oxidative/antioxidant status, inflammation, apoptosis, and mitochondrial function were assessed in addition to histopathological and electrocardiographic (ECG) evaluation. The current results revealed that Gal treatment significantly attenuated the cardiac injury and retrieved the alterations in cardiac histopathology and ECG changes. Also, it restored redox balance, as evidenced by the alleviation of malondialdehyde (MDA) levels and increased glutathione peroxidase (GPx) activity. Gal activated the sirtuin (SIRT) 1/nuclear factor erythroid 2‐related factor 2 (Nrf2)‐mediated signaling pathway, as indicated by upregulation of SIRT1, Nrf2, SIRT3, and mitochondrial transcription factor (TFAM), in addition to increased levels of superoxide dismutase 2 (SOD)2 and peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α), together with increased activity of citrate synthase (CS), pointing to improved mitochondrial function. It ameliorated the inflammation and apoptosis‐associated markers supported by biochemical and immunostaining data. Our study provided novel insights elucidating the mitigative potential of against CYP‐induced cardiac oxidative damage, inflammation, apoptosis, and mitochondrial dysfunction by upregulating the SIRT1/Nrf2/SIRT3/PGC‐1α/TFAM survival pathway.
- 7 May 2024
- Published by Wiley in Parasite Immunology
- Vol. 46 (5) , e13035
Trichinella spiralis Larval Extract as a Biological Anti‐Tumor Therapy in a Murine Model of Ehrlich Solid Carcinoma
Trichinella spiralis (T. spiralis) is an immunomodulating parasite that can adversely affect tumor growth and extend host lifespan. The aim of this study was to elucidate the mechanisms by which T. spiralis larval antigens achieve this effect using Ehrlich solid carcinoma (ESC) murine model. Assessment was done by histopathological and immunohistochemical analysis of caspase‐3, TNF‐α, Ki‐67 and CD31. Additionally, Bcl2 and Bcl2‐associated protein X (Bax) relative gene expression was assessed by molecular analysis for studying the effect of T. spiralis crude larval extract (CLE) antigen on tumor necrosis, apoptosis, cell proliferation and angiogenesis. We found that both T. spiralis infection and CLE caused a decrease in the areas of necrosis in ESC. Moreover, they led to increased apoptosis through activation of caspase‐3, up‐regulation of pro‐apoptotic gene, Bax and down‐regulation of anti‐apoptotic gene, Bcl2. Also, T. spiralis infection and CLE diminished ESC proliferation, as evidenced by decreasing Ki‐67. T. spiralis infection and CLE were able to suppress the development of ESC by inhibiting tumor proliferation, inducing apoptosis and decreasing tumor necrosis, with subsequent decrease in tumor metastasis. T. spiralis CLE antigen may be considered as a promising complementary immunotherapeutic agent in the treatment of cancer.
- 7 May 2024
- Published by Wiley in Parasite Immunology
- Vol. 46 (5) , e13035
Trichinella spiralis Larval Extract as a Biological Anti‐Tumor Therapy in a Murine Model of Ehrlich Solid Carcinoma
Trichinella spiralis (T. spiralis) is an immunomodulating parasite that can adversely affect tumor growth and extend host lifespan. The aim of this study was to elucidate the mechanisms by which T. spiralis larval antigens achieve this effect using Ehrlich solid carcinoma (ESC) murine model. Assessment was done by histopathological and immunohistochemical analysis of caspase‐3, TNF‐α, Ki‐67 and CD31. Additionally, Bcl2 and Bcl2‐associated protein X (Bax) relative gene expression was assessed by molecular analysis for studying the effect of T. spiralis crude larval extract (CLE) antigen on tumor necrosis, apoptosis, cell proliferation and angiogenesis. We found that both T. spiralis infection and CLE caused a decrease in the areas of necrosis in ESC. Moreover, they led to increased apoptosis through activation of caspase‐3, up‐regulation of pro‐apoptotic gene, Bax and down‐regulation of anti‐apoptotic gene, Bcl2. Also, T. spiralis infection and CLE diminished ESC proliferation, as evidenced by decreasing Ki‐67. T. spiralis infection and CLE were able to suppress the development of ESC by inhibiting tumor proliferation, inducing apoptosis and decreasing tumor necrosis, with subsequent decrease in tumor metastasis. T. spiralis CLE antigen may be considered as a promising complementary immunotherapeutic agent in the treatment of cancer.
- Top Cited PapersOpen Access
- 20 January 2023
- Published by Taylor & Francis in Redox Report
- Vol. 28 (1) , 2160569
Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue
Polycystic ovary syndrome (PCOS) has a series of reproductive and metabolic consequences. Although the link between PCOS, IR, and obesity, their impact on the pathogenesis of PCOS has yet to be det...
- 20 January 2023
- Published by Taylor & Francis in Redox Report
- Vol. 28 (1) , 2160569
Top Cited PapersOpen AccessNovel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue
Polycystic ovary syndrome (PCOS) has a series of reproductive and metabolic consequences. Although the link between PCOS, IR, and obesity, their impact on the pathogenesis of PCOS has yet to be det...